Background In countries banning advertising and display of tobacco at point-of-sale, little is known about tobacco companies’ continuing promotion of products through incentives and benefits to retailers.
Method A telephone survey of 4527 randomly selected Australian retailers was conducted in August 2018, and identified 800 current tobacco retailers (response rate: 72.4%) who were asked a series of questions about benefits offered to them by tobacco companies and what retailers agreed to in return.
Results 41.1% of retailers reported being provided with a tobacco cabinet and 38.3% reported having a price list supplied by a tobacco company. One-third (33.3%) reported being offered at least one benefit from a tobacco company for doing something in return. Price discounts were the most frequently reported benefit (19.0%), followed by rebates (8.4%) and gifts (3.0%). Retailers also reported offers of prizes and incentives for increasing sales or demonstrating product knowledge. In return, retailers reported giving companies benefits such as prominence on the price list and/or in the tobacco cabinet and/or influence over the product range and stock levels.
Conclusion Tobacco companies are continuing to market tobacco and influence sales through provision of incentives and benefits to retailers. Laws that ban the supply of benefits to consumers should be extended to also prohibit the provision of benefits to tobacco retailers.
- tobacco industry
- advertising and promotion
- public policy
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Twitter @WattsChrissy90, @DrBFreeman
Contributors CW, SB, KK, FP, KL, MS and SE conceptualised and designed the study. CW, SB, BF and SE interpreted and analysed the data. All authors reviewed, contributed to and approved the final manuscript.
Funding This study was funded by Cancer Council New South Wales, Cancer Council Victoria and Cancer Council Western Australia.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval Human Research Ethics Committee, Western Sydney University, Approval number H12627.
Provenance and peer review Not commissioned; externally peer reviewed.